The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival

BACKGROUND: The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a prognostic factor in patients who have some types of malignant tumors. The aim of this study was to investigate the prognostic significance of the HALP score in patients with small cell lung cancer (SCLC) before first-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xia-Bo, Zhang, Yu-Xin, Wang, Wei, Pan, Yue-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685331/
https://www.ncbi.nlm.nih.gov/pubmed/31356586
http://dx.doi.org/10.12659/MSM.917968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685331/
https://www.ncbi.nlm.nih.gov/pubmed/31356586
http://dx.doi.org/10.12659/MSM.917968

Ejemplares similares